Skip to main content
Erschienen in: European Radiology 11/2013

01.11.2013 | Urogenital

Computed diffusion-weighted imaging of the prostate at 3 T: impact on image quality and tumour detection

verfasst von: Andrew B. Rosenkrantz, Hersh Chandarana, Nicole Hindman, Fang-Ming Deng, James S. Babb, Samir S. Taneja, Christian Geppert

Erschienen in: European Radiology | Ausgabe 11/2013

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To investigate the impact of prostate computed diffusion-weighted imaging (DWI) on image quality and tumour detection.

Methods

Forty-nine patients underwent 3-T magnetic resonance imaging using a pelvic phased-array coil before prostatectomy, including DWI with b values of 50 and 1,000 s/mm2. Computed DW images with b value 1,500 s/mm2 were generated from the lower b-value images. Directly acquired b-1,500 DW images were obtained in 39 patients. Two radiologists independently assessed DWI for image quality measures and location of the dominant lesion. A third radiologist measured tumour-to-peripheral-zone (PZ) contrast. Pathological findings from prostatectomy served as the reference standard.

Results

Direct and computed b-1,500 DWI showed better suppression of benign prostate tissue than direct b-1,000 DWI for both readers (P ≤ 0.024). However, computed b-1,500 DWI showed less distortion and ghosting than direct b-1,000 and direct b-1,500 DWI for both readers (P ≤ 0.067). Direct and computed b-1,500 images showed better sensitivity and positive predictive value (PPV) for tumour detection than direct b-1,000 images for both readers (P ≤ 0.062), with no difference in sensitivity or PPV between direct and computed b-1,500 images (P ≥ 0.180). Tumour-to-PZ contrast was greater on computed b-1,500 than on either direct DWI set (P < 0.001).

Conclusion

Computed DWI of the prostate using b value ≥1,000 s/mm2 improves image quality and tumour detection compared with acquired standard b-value images.

Key Points

Diffusion weighted MRI is increasingly used for diagnosing and assessing prostate carcinoma.
Prostate computed DWI can extrapolate high b-value images from lower b values.
Computed DWI provides greater suppression of benign tissue than lower b-value images.
Computed DWI provides less distortion and artefacts than images using same b value.
Computed DWI provides better diagnostic performance than lower b-value images.
Literatur
1.
Zurück zum Zitat Barentsz JO, Richenberg J, Clements R et al (2012) ESUR prostate MR guidelines 2012. Eur Radiol 22:746–757PubMedCrossRef Barentsz JO, Richenberg J, Clements R et al (2012) ESUR prostate MR guidelines 2012. Eur Radiol 22:746–757PubMedCrossRef
2.
Zurück zum Zitat Hoeks CM, Barentsz JO, Hambrock T et al (2011) Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 261:46–66PubMedCrossRef Hoeks CM, Barentsz JO, Hambrock T et al (2011) Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 261:46–66PubMedCrossRef
3.
Zurück zum Zitat Lim HK, Kim JK, Kim KA, Cho KS (2009) Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection—a multireader study. Radiology 250:145–151PubMedCrossRef Lim HK, Kim JK, Kim KA, Cho KS (2009) Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection—a multireader study. Radiology 250:145–151PubMedCrossRef
4.
Zurück zum Zitat Haider MA, van der Kwast TH, Tanguay J et al (2007) Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 189:323–328PubMedCrossRef Haider MA, van der Kwast TH, Tanguay J et al (2007) Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 189:323–328PubMedCrossRef
5.
Zurück zum Zitat Selnaes KM, Heerschap A, Jensen LR et al (2012) Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology. Invest Radiol 47:624–633PubMedCrossRef Selnaes KM, Heerschap A, Jensen LR et al (2012) Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology. Invest Radiol 47:624–633PubMedCrossRef
6.
Zurück zum Zitat Hambrock T, Hoeks C, Hulsbergen-van de Kaa C et al (2012) Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. Eur Urol 61:177–184PubMedCrossRef Hambrock T, Hoeks C, Hulsbergen-van de Kaa C et al (2012) Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. Eur Urol 61:177–184PubMedCrossRef
7.
Zurück zum Zitat Somford DM, Hoeks CM, Hulsbergen-van de Kaa CA et al (2013) Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer. Invest Radiol 48:152–157PubMedCrossRef Somford DM, Hoeks CM, Hulsbergen-van de Kaa CA et al (2013) Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer. Invest Radiol 48:152–157PubMedCrossRef
8.
Zurück zum Zitat Somford DM, Hambrock T, Hulsbergen-van de Kaa CA et al (2012) Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series. Invest Radiol 47:153–158PubMed Somford DM, Hambrock T, Hulsbergen-van de Kaa CA et al (2012) Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series. Invest Radiol 47:153–158PubMed
9.
Zurück zum Zitat Kim CK, Park BK, Kim B (2010) Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer. AJR Am J Roentgenol 194:1461–1469PubMedCrossRef Kim CK, Park BK, Kim B (2010) Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer. AJR Am J Roentgenol 194:1461–1469PubMedCrossRef
10.
Zurück zum Zitat Vilanova JC, Barcelo-Vidal C, Comet J et al (2011) Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer. AJR Am J Roentgenol 196:W715–W722PubMedCrossRef Vilanova JC, Barcelo-Vidal C, Comet J et al (2011) Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer. AJR Am J Roentgenol 196:W715–W722PubMedCrossRef
11.
Zurück zum Zitat Tanimoto A, Nakashima J, Kohno H, Shinmoto H, Kuribayashi S (2007) Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging 25:146–152PubMedCrossRef Tanimoto A, Nakashima J, Kohno H, Shinmoto H, Kuribayashi S (2007) Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging 25:146–152PubMedCrossRef
12.
Zurück zum Zitat Vargas HA, Akin O, Shukla-Dave A et al (2012) Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study. Radiology 265:478–487PubMedCrossRef Vargas HA, Akin O, Shukla-Dave A et al (2012) Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study. Radiology 265:478–487PubMedCrossRef
13.
Zurück zum Zitat Kobus T, Vos PC, Hambrock T et al (2012) Prostate cancer aggressiveness: in vivo assessment of MR spectroscopy and diffusion-weighted imaging at 3 T. Radiology 265:457–467PubMedCrossRef Kobus T, Vos PC, Hambrock T et al (2012) Prostate cancer aggressiveness: in vivo assessment of MR spectroscopy and diffusion-weighted imaging at 3 T. Radiology 265:457–467PubMedCrossRef
14.
Zurück zum Zitat Kitajima K, Kaji Y, Kuroda K, Sugimura K (2008) High b-value diffusion-weighted imaging in normal and malignant peripheral zone tissue of the prostate: effect of signal-to-noise ratio. Magn Reson Med Sci 7:93–99PubMedCrossRef Kitajima K, Kaji Y, Kuroda K, Sugimura K (2008) High b-value diffusion-weighted imaging in normal and malignant peripheral zone tissue of the prostate: effect of signal-to-noise ratio. Magn Reson Med Sci 7:93–99PubMedCrossRef
15.
Zurück zum Zitat Kim CK, Park BK, Kim B (2010) High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. AJR Am J Roentgenol 194:W33–W37PubMedCrossRef Kim CK, Park BK, Kim B (2010) High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. AJR Am J Roentgenol 194:W33–W37PubMedCrossRef
16.
Zurück zum Zitat Metens T, Miranda D, Absil J, Matos C (2012) What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T? Eur Radiol 22:703–709PubMedCrossRef Metens T, Miranda D, Absil J, Matos C (2012) What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T? Eur Radiol 22:703–709PubMedCrossRef
17.
Zurück zum Zitat Katahira K, Takahara T, Kwee TC et al (2011) Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation. Eur Radiol 21:188–196PubMedCrossRef Katahira K, Takahara T, Kwee TC et al (2011) Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation. Eur Radiol 21:188–196PubMedCrossRef
18.
Zurück zum Zitat Ohgiya Y, Suyama J, Seino N et al (2012) Diagnostic accuracy of ultra-high-b-value 3.0-T diffusion-weighted MR imaging for detection of prostate cancer. Clin Imaging 36:526–531PubMedCrossRef Ohgiya Y, Suyama J, Seino N et al (2012) Diagnostic accuracy of ultra-high-b-value 3.0-T diffusion-weighted MR imaging for detection of prostate cancer. Clin Imaging 36:526–531PubMedCrossRef
19.
Zurück zum Zitat Kitajima K, Takahashi S, Ueno Y et al (2012) Clinical utility of apparent diffusion coefficient values obtained using high b-value when diagnosing prostate cancer using 3 tesla MRI: comparison between ultra-high b-value (2000 s/mm2) and standard high b-value (1000 s/mm2). J Magn Reson Imaging 36:198–205PubMedCrossRef Kitajima K, Takahashi S, Ueno Y et al (2012) Clinical utility of apparent diffusion coefficient values obtained using high b-value when diagnosing prostate cancer using 3 tesla MRI: comparison between ultra-high b-value (2000 s/mm2) and standard high b-value (1000 s/mm2). J Magn Reson Imaging 36:198–205PubMedCrossRef
20.
Zurück zum Zitat Ben-Amitay S, Jones DK, Assaf Y (2012) Motion correction and registration of high b-value diffusion weighted images. Magn Reson Med 67:1694–1702PubMedCrossRef Ben-Amitay S, Jones DK, Assaf Y (2012) Motion correction and registration of high b-value diffusion weighted images. Magn Reson Med 67:1694–1702PubMedCrossRef
21.
Zurück zum Zitat Blackledge MD, Leach MO, Collins DJ, Koh DM (2011) Computed diffusion-weighted MR imaging may improve tumor detection. Radiology 261:573–581PubMedCrossRef Blackledge MD, Leach MO, Collins DJ, Koh DM (2011) Computed diffusion-weighted MR imaging may improve tumor detection. Radiology 261:573–581PubMedCrossRef
22.
Zurück zum Zitat Ahmed HU (2009) The index lesion and the origin of prostate cancer. N Engl J Med 361:1704–1706PubMedCrossRef Ahmed HU (2009) The index lesion and the origin of prostate cancer. N Engl J Med 361:1704–1706PubMedCrossRef
23.
Zurück zum Zitat Bott SR, Ahmed HU, Hindley RG, Abdul-Rahman A, Freeman A, Emberton M (2010) The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer. BJU Int 106:1607–1611PubMedCrossRef Bott SR, Ahmed HU, Hindley RG, Abdul-Rahman A, Freeman A, Emberton M (2010) The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer. BJU Int 106:1607–1611PubMedCrossRef
24.
Zurück zum Zitat Karavitakis M, Winkler M, Abel P, Livni N, Beckley I, Ahmed HU (2011) Histological characteristics of the index lesion in whole-mount radical prostatectomy specimens: implications for focal therapy. Prostate Cancer Prostatic Dis 14:46–52PubMedCrossRef Karavitakis M, Winkler M, Abel P, Livni N, Beckley I, Ahmed HU (2011) Histological characteristics of the index lesion in whole-mount radical prostatectomy specimens: implications for focal therapy. Prostate Cancer Prostatic Dis 14:46–52PubMedCrossRef
25.
Zurück zum Zitat Cornfeld DM, Israel G, McCarthy SM, Weinreb JC (2008) Pelvic imaging using a T1W fat-suppressed three-dimensional dual echo Dixon technique at 3T. J Magn Reson Imaging 28:121–127PubMedCrossRef Cornfeld DM, Israel G, McCarthy SM, Weinreb JC (2008) Pelvic imaging using a T1W fat-suppressed three-dimensional dual echo Dixon technique at 3T. J Magn Reson Imaging 28:121–127PubMedCrossRef
26.
Zurück zum Zitat Hori M, Kim T, Onishi H et al (2011) Uterine tumors: comparison of 3D versus 2D T2-weighted turbo spin-echo MR imaging at 3.0 T—initial experience. Radiology 258:154–163PubMedCrossRef Hori M, Kim T, Onishi H et al (2011) Uterine tumors: comparison of 3D versus 2D T2-weighted turbo spin-echo MR imaging at 3.0 T—initial experience. Radiology 258:154–163PubMedCrossRef
27.
Zurück zum Zitat Langer DL, van der Kwast TH, Evans AJ et al (2008) Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2—sparse versus dense cancers. Radiology 249:900–908PubMedCrossRef Langer DL, van der Kwast TH, Evans AJ et al (2008) Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2—sparse versus dense cancers. Radiology 249:900–908PubMedCrossRef
28.
Zurück zum Zitat Rosenkrantz AB, Kong X, Niver BE et al (2011) Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map. AJR Am J Roentgenol 196:123–129PubMedCrossRef Rosenkrantz AB, Kong X, Niver BE et al (2011) Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map. AJR Am J Roentgenol 196:123–129PubMedCrossRef
29.
Zurück zum Zitat Liu W, Laitinen S, Khan S et al (2009) Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med 15:559–565PubMedCrossRef Liu W, Laitinen S, Khan S et al (2009) Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med 15:559–565PubMedCrossRef
30.
Zurück zum Zitat Wise AM, Stamey TA, McNeal JE, Clayton JL (2002) Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology 60:264–269PubMedCrossRef Wise AM, Stamey TA, McNeal JE, Clayton JL (2002) Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology 60:264–269PubMedCrossRef
31.
Zurück zum Zitat Rosenkrantz AB, Sigmund EE, Johnson G et al (2012) Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer. Radiology 264:126–135PubMedCrossRef Rosenkrantz AB, Sigmund EE, Johnson G et al (2012) Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer. Radiology 264:126–135PubMedCrossRef
32.
Zurück zum Zitat Quentin M, Blondin D, Klasen J et al (2012) Comparison of different mathematical models of diffusion-weighted prostate MR imaging. Magn Reson Imaging 30:1468–1474PubMedCrossRef Quentin M, Blondin D, Klasen J et al (2012) Comparison of different mathematical models of diffusion-weighted prostate MR imaging. Magn Reson Imaging 30:1468–1474PubMedCrossRef
Metadaten
Titel
Computed diffusion-weighted imaging of the prostate at 3 T: impact on image quality and tumour detection
verfasst von
Andrew B. Rosenkrantz
Hersh Chandarana
Nicole Hindman
Fang-Ming Deng
James S. Babb
Samir S. Taneja
Christian Geppert
Publikationsdatum
01.11.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 11/2013
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-013-2917-8

Weitere Artikel der Ausgabe 11/2013

European Radiology 11/2013 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.